• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

  • P2: Movement Disorders: Clinical Trials in Parkinson

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 9 of 9

  • Page:
  • 1
  • 2

Characterizing a Parkinson's Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa

Author:Odin, Per   Pahwa, Rajesh   Farmer, Jill   Kimber, Thomas   Bergmans, Bruno   Freire Alvarez, Eric   Ray Chaudhuri, K   Gupta, Resmi   Yan, Connie H.   Bergmann, Lars   Kukreja, Pavnit   Antonini, Angelo   

Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P2.006  

Author Institution:Lund University, Lund, Sweden, Bermerhaven, Germany  University of Kansas Medical Center, Kansas City, KS, USA, Kansas City, KS  Global Neurosciences Institute, Pennington, NJ, USA, Pennington, NJ  Royal Adelaide Hospital, Adelaide, Australia, Beulah Park, Australia  AZ St-Jan Brugge-Oostende AV, Bruges, Belgium and Ghent University Hospital, Ghent, Belgium, Bruges, Belgium  University General Hospital of Elche, Elche, Spain, Elche, Spain  King's College Hospital, London, UK, London, United Kingdom  AbbVie Inc., North Chicago, IL, USA, North Chicago, IL  AbbVie Inc., North Chicago, IL, USA, Ludwigshafen, Germany  University of Padua, Padua, Italy, Padova, Italy  

  • View Abstract
  • View Disclosure

Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD

Author:D'Urso, Giulia   Thomann, Alessandra   Anzures-Cabrera, Judith   Zinnhardt, Bastian   Ricci, Benedicte   Bailey, Lorna   Smigorski, Krzysztof   Machado, Venissa   Mracskó, Eva Zsuszsanna   Pavese, Nicola   Marek, Kenneth   Brockmann, Kathrin   Simuni, Tanya   Milani Muelhardt, Nicoletta   Pagano, Gennaro   

Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P2.007  

Author Institution:F. Hoffmann - La Roche Ltd, Basel, Switzerland  F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom  Newcastle University, Newcastle upon Tyne, England, United Kingdom  Invicro, A Konica Minolta Company, Boston, MA  University Hospital Tuebingen, Tubingen, Germany  Northwestern University Feinberg School of Medicien, Chicago, IL  

  • View Abstract
  • View Disclosure

Optimizing Augmented Reality Cueing Strategies for Freezing of Gait in Parkinson Disease: Interim Results of the ELIMINATE FoG Study

Author:Baugher, Brendan   Kaya, Ryan   Scelina, Kathryn   Ghosh, Debolina   Amato, Alexa   Baker, Ken   Fernandez, Hubert H.   Alberts, Jay   Szewcyzk, Nathaniel   Liao, James   

Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P2.008  

Author Institution:Ohio University and Cleveland Clinic, Cleveland, OH  Cleveland Clinic , Cleveland, OH  Cleveland Clinic, Cleveland, OH  Case Western Reserve University School of Medicine, Cleveland, OH  Ohio University, Athens, OH  

  • View Abstract
  • View Disclosure

BCR-ABL Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review

Author:Berton, Giovanni   Lima, Amanda   Borges, Rafael   Cardoso, Nicole   Marques, Marcos   Oliveira, Thiago   

Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P2.009  

Author Institution:University of Passo Fundo, Passo Fundo, Brazil  Universidade Positivo, Curitiba, Brazil  Federal University of Minas Gerais - Medical School, Belo Horizonte, Brazil  Faculdade Santa Marcelina, São Paulo, Brazil  Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil  Universidade Federal de Minas Gerais, Belo Horizonte, Brazil  

  • View Abstract
  • View Disclosure

Displaying 6 - 9 of 9

  • Page:
  • 1
  • 2

© 2015 Mira Smart Conference | http://www.mirasmart.com